The transplantation of adult stem cells into a Type-1 Diabetes animal model has revealed the importance of blood vessels in pancreatic beta cell regeneration.
Researchers led by Dr. Habib Zaghouani from the University of Missouri have developed a potential cure to Type 1 Diabetes by utilizing mesenchymal stem cells [MSCs]. Although researchers anticipated that the MSCs would differentiate into new insulin producing pancreatic beta cells, they discovered that the stem cells fulfilled the more critical function of repairing damaged blood vessels, which in turn facilitated the regeneration of insulin producing pancreatic beta cells and the distribution of insulin across the body. Continue reading →
A research team led by Doctor Alexander Seifalian at University College London is currently creating custom lab-grown organs and body parts for patients utilizing autologous [the patient’s own] stem cells. The scientists have engineered a polymer material that they mold into the shape of an organ in need, infuse with the patient’s stem cells, and then transplant back onto the patient’s body. Continue reading →
MSCs can promote other stem cells into organizing into new tissues, organs, and vascularization.
Researchers at University of Illinois at Chicago have discovered an ability of mesenchymal stem cells [the type of stem cells found in teeth] to facilitate the growth of new blood vessels. MSCs promotion of vascularization is critical, not only for the repair of damaged tissue and organs, but for the development of new organs as well. Continue reading →
The Science Channel explores the use of stem cells in regenerative medicine
As seen on the Science Channel’s “Futurescape” program, the host of the program, James Woods takes viewers on a journey of discovery as he explores the field of regenerative medicine and life extension. The program examines current and future applications of stem cells to grow organs and tissue to treat disease, trauma and injury as well as efforts to increase life expectancy and mitigate the effects of aging. Continue reading →
In a pre-clinical trial, Researchers at the National University of Ireland Galway have found that mesenchymal stem cells (MSCs) demonstrate the ability to increase wound healing for diabetics’ related wounds. Diabetic patients have impaired ability to heal wounds with 25% of diabetic patients affected by foot ulcers; which may result in amputation.